ATLN Stock: Atlantic International Corp. Stock Price, Analysis & Insights
Get live atln stock price $1.83, comprehensive Atlantic International Corp. stock analysis, charts, news, and expert forecast. Real-time atln stock data and investment insights.
Loading chart...
Company Overview
As of June 18, 2024, Atlantic International Corp. was acquired by Lyneer Investments, LLC, in a reverse merger transaction. Atlantic International Corp. operates as a life sciences instrumentation and research services company. It focuses on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provides solutions for various applications, such as biomarker discovery and diagnostic assay developments, including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justice's Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and Weizmann Institute of Science for developed and applied innovative single-molecule technologies. The company was formerly known as SeqLL Inc. and changed its name to Atlantic International Corp. in June 2024. The company was founded in 2013 and is headquartered in Billerica, Massachusetts.
Company Information
- CEO
- Jeffrey Jagid
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 300
Contact Information
- Website
- https://seqll.com
- Address
- 3 Federal Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Listed on major US exchange (NASDAQ) providing liquidity and transparency
Business Model & Strategy
Atlantic International Corp. operates in the Medical - Diagnostics & Research industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Jeffrey Jagid, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Diagnostics & Research model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Atlantic International Corp. competes in the Medical - Diagnostics & Research within the broader Healthcare. With 99.4 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ, Atlantic International Corp. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Atlantic International Corp. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Atlantic International Corp. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Atlantic International Corp.
- ⚠Investors should consider how Atlantic International Corp. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
99.43M
P/E Ratio
-0.82
Beta
1.12
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 99.43M market capitalization
- Trading Volume: 31.50K shares traded today
- Price Range: 52-week range of $1.45 - $7.97
- Exchange: Listed on NASDAQ
Financial Metrics
Market Analysis for Atlantic International Corp.
Atlantic International Corp. (ATLN) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. With a current market capitalization of 99.43M, the company represents a significant player in its market. The stock is currently trading at $1.83 with a negativedaily change of 19.74%.
The company's 300 employee base and presence on the NASDAQexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.82, beta of 1.12, and 52-week price range from $1.45 to $7.97when evaluating investment opportunities.
Why Invest in Atlantic International Corp.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ)
- • Experienced leadership under Jeffrey Jagid
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.